330 related articles for article (PubMed ID: 11976263)
1. Molecular and pharmacological characterization of genes encoding urotensin-II peptides and their cognate G-protein-coupled receptors from the mouse and monkey.
Elshourbagy NA; Douglas SA; Shabon U; Harrison S; Duddy G; Sechler JL; Ao Z; Maleeff BE; Naselsky D; Disa J; Aiyar NV
Br J Pharmacol; 2002 May; 136(1):9-22. PubMed ID: 11976263
[TBL] [Abstract][Full Text] [Related]
2. Identification and pharmacological characterization of native, functional human urotensin-II receptors in rhabdomyosarcoma cell lines.
Douglas SA; Naselsky D; Ao Z; Disa J; Herold CL; Lynch F; Aiyar NV
Br J Pharmacol; 2004 Jul; 142(6):921-32. PubMed ID: 15210573
[TBL] [Abstract][Full Text] [Related]
3. Cloning and pharmacological characterization of the cat urotensin-II receptor (UT).
Aiyar N; Johns DG; Ao Z; Disa J; Behm DJ; Foley JJ; Buckley PT; Sarau HM; van-der-Keyl HK; Elshourbagy NA; Douglas SA
Biochem Pharmacol; 2005 Apr; 69(7):1069-79. PubMed ID: 15763543
[TBL] [Abstract][Full Text] [Related]
4. Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.
Douglas SA; Behm DJ; Aiyar NV; Naselsky D; Disa J; Brooks DP; Ohlstein EH; Gleason JG; Sarau HM; Foley JJ; Buckley PT; Schmidt DB; Wixted WE; Widdowson K; Riley G; Jin J; Gallagher TF; Schmidt SJ; Ridgers L; Christmann LT; Keenan RM; Knight SD; Dhanak D
Br J Pharmacol; 2005 Jul; 145(5):620-35. PubMed ID: 15852036
[TBL] [Abstract][Full Text] [Related]
5. Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14.
Ames RS; Sarau HM; Chambers JK; Willette RN; Aiyar NV; Romanic AM; Louden CS; Foley JJ; Sauermelch CF; Coatney RW; Ao Z; Disa J; Holmes SD; Stadel JM; Martin JD; Liu WS; Glover GI; Wilson S; McNulty DE; Ellis CE; Elshourbagy NA; Shabon U; Trill JJ; Hay DW; Ohlstein EH; Bergsma DJ; Douglas SA
Nature; 1999 Sep; 401(6750):282-6. PubMed ID: 10499587
[TBL] [Abstract][Full Text] [Related]
6. The peptidic urotensin-II receptor ligand GSK248451 possesses less intrinsic activity than the low-efficacy partial agonists SB-710411 and urantide in native mammalian tissues and recombinant cell systems.
Behm DJ; Stankus G; Doe CP; Willette RN; Sarau HM; Foley JJ; Schmidt DB; Nuthulaganti P; Fornwald JA; Ames RS; Lambert DG; Calo' G; Camarda V; Aiyar NV; Douglas SA
Br J Pharmacol; 2006 May; 148(2):173-90. PubMed ID: 16547525
[TBL] [Abstract][Full Text] [Related]
7. Elevated expression of urotensin II and its receptor in skeletal muscle of diabetic mouse.
Wang HX; Zeng XJ; Liu Y; Wang J; Lu LQ; Hao G; Zhang LK; Tang CS
Regul Pept; 2009 Apr; 154(1-3):85-90. PubMed ID: 19323985
[TBL] [Abstract][Full Text] [Related]
8. Characterization of functional urotensin II receptors in human skeletal muscle myoblasts: comparison with angiotensin II receptors.
Qi JS; Minor LK; Smith C; Hu B; Yang J; Andrade-Gordon P; Damiano B
Peptides; 2005 Apr; 26(4):683-90. PubMed ID: 15752584
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of binding sites for human urotensin-II in Sprague-Dawley rat renal medulla using quantitative receptor autoradiography.
Disa J; Floyd LE; Edwards RM; Douglas SA; Aiyar NV
Peptides; 2006 Jun; 27(6):1532-7. PubMed ID: 16290260
[TBL] [Abstract][Full Text] [Related]
10. Photolabelling the urotensin II receptor reveals distinct agonist- and partial-agonist-binding sites.
Holleran BJ; Beaulieu ME; Proulx CD; Lavigne P; Escher E; Leduc R
Biochem J; 2007 Feb; 402(1):51-61. PubMed ID: 17064254
[TBL] [Abstract][Full Text] [Related]
11. Differential agonistic and antagonistic effects of the urotensin-II ligand SB-710411 at rodent and primate UT receptors.
Behm DJ; Herold CL; Camarda V; Aiyar NV; Douglas SA
Eur J Pharmacol; 2004 May; 492(2-3):113-6. PubMed ID: 15178353
[TBL] [Abstract][Full Text] [Related]
12. Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.
Boucard AA; Sauvé SS; Guillemette G; Escher E; Leduc R
Biochem J; 2003 Mar; 370(Pt 3):829-38. PubMed ID: 12495432
[TBL] [Abstract][Full Text] [Related]
13. Urotensin II is the endogenous ligand of a G-protein-coupled orphan receptor, SENR (GPR14).
Mori M; Sugo T; Abe M; Shimomura Y; Kurihara M; Kitada C; Kikuchi K; Shintani Y; Kurokawa T; Onda H; Nishimura O; Fujino M
Biochem Biophys Res Commun; 1999 Nov; 265(1):123-9. PubMed ID: 10548501
[TBL] [Abstract][Full Text] [Related]
14. Identification of urotensin II as the endogenous ligand for the orphan G-protein-coupled receptor GPR14.
Liu Q; Pong SS; Zeng Z; Zhang Q; Howard AD; Williams DL; Davidoff M; Wang R; Austin CP; McDonald TP; Bai C; George SR; Evans JF; Caskey CT
Biochem Biophys Res Commun; 1999 Dec; 266(1):174-8. PubMed ID: 10581185
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of putative peptidic urotensin-II receptor antagonists on urotensin-II-induced contraction of cat isolated respiratory smooth muscle.
Behm DJ; Ao Z; Camarda V; Aiyar NV; Johns DG; Douglas SA
Eur J Pharmacol; 2005 Jun; 516(3):276-81. PubMed ID: 15975570
[TBL] [Abstract][Full Text] [Related]
16. Ligand-supported purification of the urotensin-II receptor.
Du AT; Onan D; Dinh DT; Lew MJ; Ziogas J; Aguilar MI; Pattenden LK; Thomas WG
Mol Pharmacol; 2010 Oct; 78(4):639-47. PubMed ID: 20647393
[TBL] [Abstract][Full Text] [Related]
17. A new ligand for the urotensin II receptor.
Camarda V; Guerrini R; Kostenis E; Rizzi A; Calò G; Hattenberger A; Zucchini M; Salvadori S; Regoli D
Br J Pharmacol; 2002 Oct; 137(3):311-4. PubMed ID: 12237249
[TBL] [Abstract][Full Text] [Related]
18. Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues.
Behm DJ; McAtee JJ; Dodson JW; Neeb MJ; Fries HE; Evans CA; Hernandez RR; Hoffman KD; Harrison SM; Lai JM; Wu C; Aiyar NV; Ohlstein EH; Douglas SA
Br J Pharmacol; 2008 Oct; 155(3):374-86. PubMed ID: 18587423
[TBL] [Abstract][Full Text] [Related]
19. UII and UT in grouper: cloning and effects on the transcription of hormones related to growth control.
Sun C; Duan D; Li B; Qin C; Jia J; Wang B; Dong H; Li W
J Endocrinol; 2014 Jan; 220(1):35-48. PubMed ID: 24169050
[TBL] [Abstract][Full Text] [Related]
20. Alteration of vascular urotensin II receptor in mice with apolipoprotein E gene knockout.
Wang ZJ; Shi LB; Xiong ZW; Zhang LF; Meng L; Bu DF; Tang CS; Ding WH
Peptides; 2006 Apr; 27(4):858-63. PubMed ID: 16325305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
